Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma

Clinical trial NCT00834665 · COMPLETED

Trial details

NCT number: NCT00834665
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2006-12-01
Primary completion: 2017-12-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.